Insulin resistance and glucose homeostasis in peritoneal dialysis

Peritoneal Dialysis International

Volumn 29, Issue SUPPL. 2, 2009, Pages

  Fortes, Paulo Cezar ^a   de Moraes, Thyago Proença ^a   Mendes, Jamille Godoy ^a   Stinghen, Andrea E ^a   Ribeiro, Silvia Carreira ^a   Pecoits Filho, Roberto ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Chronic kidney disease; Insulin resistance

Indexed keywords

CYTOKINE; DIALYSIS FLUID; FATTY ACID; GLUCOSE; ICODEXTRIN; INSULIN; PERITONEAL DIALYSIS FLUID; ROSIGLITAZONE;

ANEMIA; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE COURSE; DISORDERS OF CARBOHYDRATE METABOLISM; DRUG ABSORPTION; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MECHANISM; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; INSULIN RESISTANCE; MALNUTRITION; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; METABOLIC ACIDOSIS; METABOLIC DISORDER; PATHOGENESIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SOLUTE; SURVIVAL RATE; UREMIA; VITAMIN D DEFICIENCY; BLOOD; CHRONIC KIDNEY FAILURE; GLUCOSE BLOOD LEVEL; METABOLIC SYNDROME X; METABOLISM; MORBIDITY; PHYSIOLOGY; PROGNOSIS; REVIEW;

BLOOD GLUCOSE; DYSLIPIDEMIAS; HUMANS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; METABOLIC SYNDROME X; MORBIDITY; PERITONEAL DIALYSIS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 67449105018     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902902s28     Document Type: Conference Paper

References (12)

1. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67:563-8.
2. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111:1448-54.
3. El-Atat FA, Stas SN, McFarlane SI, Sowers JR. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004; 15:2816-27.
4. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115:1111-19.
5. Fortes PC, Mendes JG, Riella MC, Pecoits-Filho R. Carbohydrate metabolism disturbances in non-diabetic patients on peritoneal dialysis [Abstract]. Perit Dial Int 2006; 26(Suppl 2):S26.
6. Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK. New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis 2007; 49: 524-32.
7. Szeto CC, Chow KM, Leung CB, Kwan BC, Chung KY, Law MC, et al. Increased subcutaneous insulin requirements in diabetic patients recently commenced on peritoneal dialysis. Nephrol Dial Transplant 2007; 22:1697-702.
8. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13:1894-900.
9. Chen HY, Kao TW, Huang JW, Chu TS, Wu KD. Correlation of metabolic syndrome with residual renal function, solute transport rate and peritoneal solute clearance in chronic peritoneal dialysis patients. Blood Purif 2008; 26:138-44.
10. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, et al. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 2005; 16:3411-17.
11. Wong TY, Szeto CC, Chow KM, Leung CB, Lam CW, Li PK. Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis. Am J Kidney Dis 2005; 46:713-19.
12. Takeguchi F, Nakayama M, Nakao T. Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis. Ther Apher Dial 2008; 12: 243-9.